ENDRA Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 May 23 | BuyUS$24,750 | Michael Thornton | Individual | 15,000 | US$1.65 | |
02 May 23 | BuyUS$100,000 | Anthony DiGiandomenico | Individual | 83,333 | US$1.20 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,983 | 0.027% |
Institutions | 141,814 | 1.29% |
Individual Insiders | 348,066 | 3.15% |
General Public | 10,542,796 | 95.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 248.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
192,500 | US$179.0k | 0% | no data | |||
102,434 | US$95.3k | 0% | no data | |||
52,183 | US$48.5k | 5.7% | no data | |||
39,812 | US$37.0k | 2.24% | no data | |||
34,139 | US$31.7k | 0% | no data | |||
31,257 | US$29.1k | -2.52% | no data | |||
13,888 | US$12.9k | 0% | 0.01% | |||
8,143 | US$7.6k | 0% | no data | |||
4,860 | US$4.5k | 0% | no data | |||
3,457 | US$3.2k | 0% | no data | |||
3,227 | US$3.0k | 310% | no data | |||
2,983 | US$2.8k | -59.8% | no data | |||
2,454 | US$2.3k | 0% | no data | |||
869 | US$807.7 | 0% | no data | |||
332 | US$308.9 | -57.5% | no data | |||
329 | US$305.8 | 0% | no data | |||
103 | US$95.4 | 0% | no data | |||
79 | US$73.9 | 0% | no data | |||
58 | US$54.4 | 5.45% | no data | |||
1 | US$1.0 | 0% | no data |